MiR-483-5p suppresses the proliferation of glioma cells via directly targeting ERK1

FEBS Letters

Volumn 586, Issue 9, 2012, Pages 1312-1317

  Wang, Li ^a   Shi, Ming ^a   Hou, Shuangxing ^a   Ding, Bojun ^a   Liu, Lijuan ^a   Ji, Xituan ^a   Zhang, Jian ^b   Deng, Yanchun ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

miR 483 5p cell proliferation ERK1 glioma

Indexed keywords

MICRORNA; MIR 483 5P; MITOGEN ACTIVATED PROTEIN KINASE 3; UNCLASSIFIED DRUG;

ARTICLE; BRAIN TISSUE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME INACTIVATION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC ANALYSIS; GENETIC REGULATION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; REPORTER GENE; TISSUE PREPARATION; TUMOR CELL LINE; TUMOR GROWTH;

BASE SEQUENCE; BRAIN; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; G1 PHASE CELL CYCLE CHECKPOINTS; GLIOMA; HUMANS; MICRORNAS; MITOGEN-ACTIVATED PROTEIN KINASE 3;

EID: 84860324785     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2012.03.035     Document Type: Article

References (25)

1. R.J. Komotar, M.L. Otten, G. Moise, and E.S. Connolly Jr. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma-a critical review Clin. Med. Oncol. 2 2008 421 422
2. D.P. Bartel MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 2004 281 297
3. C.Z. Chen MicroRNAs as oncogenes and tumor suppressors N. Engl. J. Med. 353 2005 1768 1771
4. M.F. Corsten, R. Miranda, R. Kasmieh, A.M. Krichevsky, R. Weissleder, and K. Shah MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas Cancer Res. 67 2007 8994 9000 (Pubitemid 47535880)
5. G. Gabriely, T. Wurdinger, S. Kesari, C.C. Esau, J. Burchard, P.S. Linsley, and A.M. Krichevsky MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators Mol. Cell. Biol. 28 2008 5369 5380
6. L. Shi, J. Chen, J. Yang, T. Pan, S. Zhang, and Z. Wang MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity Brain Res. 1352 2010 255 264
7. V.G. Tusher, R. Tibshirani, and G. Chu Significance analysis of microarrays applied to the ionizing radiation response Proc. Natl. Acad. Sci. U S A 98 2001 5116 5121 (Pubitemid 32397092)
8. C. Chen, D.A. Ridzon, A.J. Broomer, Z. Zhou, D.H. Lee, J.T. Nguyen, M. Barbisin, N.L. Xu, V.R. Mahuvakar, M.R. Andersen, K.Q. Lao, K.J. Livak, and K.J. Guegler Real-time quantification of microRNAs by stem-loop RT-PCR Nucleic Acids Res. 33 2005 e179
9. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods 25 2001 402 408 (Pubitemid 34164012)
10. T.R. Brummelkamp, R. Bernards, and R. Agami A system for stable expression of short interfering RNAs in mammalian cells Science 296 2002 550 553 (Pubitemid 34408678)
11. K.K. Li, J.C. Pang, A.K. Ching, C.K. Wong, X. Kong, Y. Wang, L. Zhou, Z. Chen, and H.K. Ng MiR-124 is frequently down-regulated in medulloblastoma and is a negative regulator of SLC16A1 Hum. Pathol. 40 2009 1234 1243
12. B. Kefas, J. Godlewski, L. Comeau, Y. Li, R. Abounader, M. Hawkinson, J. Lee, H. Fine, E.A. Chiocca, S. Lawler, and B. Purow MicroRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma Cancer Res. 68 2008 3566 3572
13. J. Godlewski, M.O. Nowicki, A. Bronisz, S. Williams, A. Otsuki, G. Nuovo, A. Raychaudhury, H.B. Newton, E.A. Chiocca, and S. Lawler Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal Cancer Res. 68 2008 9125 9130
14. P.S. Soon, L.J. Tacon, A.J. Gill, C.P. Bambach, M.S. Sywak, P.R. Campbell, M.W. Yeh, S.G. Wong, R.J. Clifton-Bligh, B.G. Robinson, and S.B. Sidhu MiR-195 and miR-483-5p Identified as Predictors of Poor Prognosis in Adrenocortical Cancer Clin. Cancer Res. 15 2009 7684 7692
15. G.Y. Meyer-Rochow, N.E. Jackson, J.V. Conaglen, D.E. Whittle, M. Kunnimalaiyaan, H. Chen, G. Westin, J. Sandgren, P. Stalberg, E. Khanafshar, D. Shibru, Q.Y. Duh, O.H. Clark, E. Kebebew, A.J. Gill, R. Clifton-Bligh, B.G. Robinson, D.E. Benn, and S.B. Sidhu MicroRNA profiling of benign and malignant pheochromocytomas identifies novel diagnostic and therapeutic targets Endocr. Relat. Cancer 17 2010 835 846
16. E.E. Patterson, A.K. Holloway, J. Weng, T. Fojo, and E. Kebebew MicroRNA profiling of adrenocortical tumors reveals miR-483 as a marker of malignancy Cancer 117 2011 1630 1639
17. G.A. Calin, C.D. Dumitru, M. Shimizu, R. Bichi, S. Zupo, E. Noch, H. Aldler, S. Rattan, M. Keating, K. Rai, L. Rassenti, T. Kipps, M. Negrini, F. Bullrich, and C.M. Croce Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia Proc. Natl. Acad. Sci. U S A 99 2002 15524 15529 (Pubitemid 35403967)
18. E.J. Lee, Y. Gusev, J. Jiang, G.J. Nuovo, M.R. Lerner, W.L. Frankel, D.L. Morgan, R.G. Postier, D.J. Brackett, and T.D. Schmittgen Expression profiling identifies microRNA signature in pancreatic cancer Int. J. Cancer 120 2007 1046 1054 (Pubitemid 46214304)
19. S. Valastyan, F. Reinhardt, N. Benaich, D. Calogrias, A.M. Szasz, Z.C. Wang, J.E. Brock, A.L. Richardson, and R.A. Weinberg A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis Cell 137 2009 1032 1046
20. S. Meloche, and J. Pouyssegur The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition Oncogene 26 2007 3227 3239 (Pubitemid 46763017)
21. G. Pearson, F. Robinson, T. Beers Gibson, B.E. Xu, M. Karandikar, K. Berman, and M.H. Cobb Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions Endocr. Rev. 22 2001 153 183 (Pubitemid 32458157)
22. Y.D. Shaul, and R. Seger The MEK/ERK cascade: from signaling specificity to diverse functions Biochim. Biophys. Acta 1773 2007 1213 1226 (Pubitemid 47125968)
23. Y. Qiao, N. Ma, X. Wang, Y. Hui, F. Li, Y. Xiang, J. Zhou, C. Zou, J. Jin, G. Lv, H. Jin, and X. Gao MiR-483-5p controls angiogenesis in vitro and targets serum response factor FEBS Lett. 585 2011 3095 3100
24. X. Liu, S. Yan, T. Zhou, Y. Terada, and R.L. Erikson The MAP kinase pathway is required for entry into mitosis and cell survival Oncogene 23 2004 763 776 (Pubitemid 38241277)
25. C. Fremin, F. Ezan, P. Boisselier, A. Bessard, G. Pages, J. Pouyssegur, and G. Baffet ERK2 but not ERK1 plays a key role in hepatocyte replication: an RNAi-mediated ERK2 knockdown approach in wild-type and ERK1 null hepatocytes Hepatology 45 2007 1035 1045 (Pubitemid 46631572)